Whether you are considering the possibility of a fertility journey, or you are mid-way through your journey, it is a profoundly personal and often complex experience.

In the field of assisted reproductive technology, advancements in genetic testing have paved the way for more informed and precise family planning. 

In this article, we aim to demystify the world of genetic testing, focusing on two crucial procedures: Preimplantation Genetic Testing for Aneuploidy (PGT-A) and Preimplantation Genetic Testing for Monogenic Disorders (PGT-M). 

These cutting-edge technologies offer assistance and hope to couples who are navigating the challenges of fertility by providing insights into chromosomal health and the prevention of specific genetic conditions.

Join us as we delve into the benefits of PGT-A and PGT-M, unravelling the science behind these revolutionary procedures and understanding how they can shape the future of your family.

First things first, let’s explain the objectives of the two tests.

Red illuminated doorway in dimly lit corridor

What is the purpose of the PGT-A Test?

Preimplantation Genetic Testing for Aneuploidy, is a transformative screening process designed to examine embryos for chromosomal abnormalities, particularly aneuploidy.

Aneuploidy, which refers to an abnormal number of chromosomes in an embryo, holds implications for the success of a pregnancy. 

The human body typically comprises 23 pairs of chromosomes, contributing to our genetic makeup. Chromosomes 1-22 form the first set, and the final pair determines our biological sex—XX for females and XY for males. 

Any deviation from this delicate chromosomal balance can lead to developmental issues, miscarriages, or the birth of a child with genetic conditions.

PGT-A’s primary goal is to identify embryos with the correct number of chromosomes, a crucial factor in optimizing the chances of a successful pregnancy. 

This meticulous screening is particularly recommended for couples facing various challenges on their fertility journey.

What are the Benefits of PGT-A Testing?

Essentially, PGT-A testing helps couples to identify any chromosomal abnormalities.

The immediate benefits of PGT-A Testing are listed below:

  • Increased Pregnancy Rates per Transfer: PGT-A significantly enhances the success rates of IVF by selecting embryos with optimal chromosomal configurations.
  • Reduced Time between IVF Cycles: By streamlining the embryo selection process, PGT-A minimizes the time between IVF cycles, expediting the overall journey to pregnancy.
  • Reduced Miscarriage Rates: Identifying chromosomally normal embryos lowers the risk of miscarriage, offering emotional relief to couples who have experienced the heartbreak of pregnancy loss.
  • Increased Confidence in Single Embryo Transfers: PGT-A instils confidence in the viability of individual embryos, encouraging the practice of single embryo transfers. This approach not only minimizes the risks associated with multiple pregnancies but also prioritizes the health and well-being of both the mother and the developing child.

In essence, PGT-A is not merely a scientific procedure but a compass guiding families through the complexities of fertility treatments. It empowers individuals to make informed decisions, offering a glimpse of the future and the potential for a successful and healthy pregnancy. 

As the frontier of reproductive science continues to advance, PGT-A stands as a testament to the possibilities and advancements in creating life.

Red House on a Hill

What is a PGT-M Test? 

Tailored for couples facing the challenge of a known mutation causing hereditary conditions like Cystic Fibrosis or Tay-Sachs Disease, PGT-M is a necessary tool for family planning.

What is PGT-M?

PGT-M is a laboratory test designed to screen embryos created through IVF for specific genetic disorders caused by a single gene mutation. By identifying embryos without the targeted genetic mutation, PGT-M aims to break the cycle of hereditary conditions. This offers families the opportunity to conceive without passing on the associated disorders.

Who Can Benefit from PGT-M?

This groundbreaking testing is particularly relevant for individuals and couples with a high risk of passing on a single-gene disorder:

  • Couples Carrying Autosomal Recessive Conditions (e.g., Cystic Fibrosis)
  • Carriers of X-Linked Conditions (e.g., Duchenne Muscular Dystrophy)
  • Couples with Autosomal Dominant Conditions (e.g., Huntington’s Disease):
  • Couples with Mutations Linked to Hereditary Cancer Syndromes (e.g., BRCA1 & 2)
  • Couples with Previous Single Gene Disorder in Child or Pregnancy: Families who have experienced the challenges of a single gene disorder in a previous child or pregnancy find reassurance in PGT-M. This testing enables them to make informed choices, reducing the likelihood of a recurrence.

In the dance of genetics and reproductive science, PGT-M empowers families to make informed choices and embark on the journey of parenthood with increased confidence.

The PGT-M Testing Process 

Let’s have a look at the steps that are undertaken during a PGT-M Test:

  • Test Design: A detailed process begins with the creation of DNA markers around the targeted gene, ensuring a tailored approach to each family’s unique mutation. This phase, facilitated by linkage analysis, is the foundation for developing a PGT-M test that aligns with the family’s genetic profile.
  • IVF Procedure: Following the design phase, the in vitro fertilization (IVF) journey commences. During IVF, embryos are created outside the body in a controlled environment. This allows for a strategic approach to select embryos free from the identified genetic mutation, enhancing the prospects of a healthy pregnancy.
  • Embryo Sampling: On day 5 or day 6 of embryonic development, a small, carefully extracted sample is taken from the selected embryo. This process ensures minimal disruption to the embryo’s natural progression while providing the necessary genetic material for testing.
  • Embryo Freezing: The sampled embryo is then delicately frozen, preserving its viability for future use. Meanwhile, the extracted sample is securely transported to the laboratory for comprehensive genetic testing.
  • Laboratory Testing: In the laboratory, the extracted sample undergoes thorough testing to identify whether the targeted genetic mutation is present. This stage is a crucial checkpoint to determine the suitability of the embryo for implantation.

By incorporating cutting-edge technology and a personalized approach, the PGT-M testing process not only aims to identify and mitigate the risk of familial genetic conditions but also streamlines the journey toward a successful pregnancy. 

Families can take comfort in the efficiency, precision, and hope that PGT-M testing brings to the forefront of assisted reproductive technology, ushering in a new era of informed family planning.

Man on the street with a red umbrella

Exploring some real-world scenarios for a better understanding:

Let us take a look at some scenarios in which genetic testing has been beneficial to couples;

Case Study 1: Navigating Recurrent Pregnancy Loss with PGT-A and PGT-M Testing 

Patient Profile:

Names: Thandiwe and Junior Nkogatsi

Age: Thandi (36), Junior (38)

Medical History: Recurrent pregnancy losses both naturally and through multiple IVF cycles

Background: Thandi and Junior have been on a challenging fertility journey, marked by the heartbreak of recurrent pregnancy losses. Despite multiple attempts at in vitro fertilization (IVF), they faced the emotional toll of miscarriages, leaving them seeking answers and hope for a successful pregnancy.

Consultation and Recommendation: After thorough consultation with their fertility specialist, the couple was recommended a combination of Preimplantation Genetic Testing for Aneuploidy (PGT-A) and Preimplantation Genetic Testing for Monogenic Disorders (PGT-M).

PGT-A Testing: Objective: To screen embryos for chromosomal abnormalities and ensure the correct number of chromosomes for a successful pregnancy.

PGT-M Testing: Objective: To screen embryos for a specific genetic mutation associated with recurrent pregnancy losses.

Outcome: The combined approach of PGT-A and PGT-M provided the Nkogatsi’s with invaluable insights into the genetic health of their embryos. Embryos free from aneuploidy and the specific genetic mutation were identified, offering a promising path towards a successful pregnancy.

Next Steps: Armed with this comprehensive genetic information, the couple could confidently proceed with a single embryo transfer during their next IVF cycle, reducing the risk of miscarriage and increasing the chances of a healthy pregnancy.

Case Study 2: Navigating X-Linked Challenges – The Andersons’ Fertility Journey 

Names: Emily and Michael Anderson

Ages: Emily (34), Michael (36)

Background: Emily and Michael Anderson had been trying to expand their family for several years but were faced with the emotional challenges of unexplained infertility. Seeking answers, they consulted with a fertility specialist who conducted thorough assessments, revealing that Emily was a carrier of an X-linked genetic condition.


Carrier of X-Linked Condition: Emily carried an X-linked genetic condition, which meant that any male offspring had a higher risk of inheriting the mutation, potentially leading to health complications.

Importance of Child’s Sex: Given the nature of the X-linked condition, the sex of the child became a crucial factor in the Andersons’ family planning. They desired a method that would enable them to conceive while minimizing the risk of passing on the genetic condition.

Consultation and Recommendation: Upon understanding the challenges faced by the Andersons, their fertility specialist recommended Preimplantation Genetic Testing for Monogenic Disorders (PGT-M) as a tailored solution to address the X-linked genetic condition.

PGT-M Testing: Objective: To screen embryos for a specific X-linked genetic mutation, ensuring a healthy pregnancy with minimized risk.

Process: A customized PGT-M test was designed to target the specific X-linked genetic mutation carried by Emily.

Outcome: The PGT-M testing provided the Andersons with clarity and a path forward in their fertility journey. 

Next Steps: Empowered by the insights from PGT-M testing, Emily and Michael could move forward with greater confidence in their family planning. 

During conception, the power of knowledge becomes a transformative force, and genetic testing emerges as a crucial tool. 

These technologies are not only scientific marvels but also essential resources. They serve as the keys to unlocking a future where families can make informed choices, reducing risks and increasing the likelihood of a healthy pregnancy. 

Whether your focus is on understanding chromosomal health with PGT-A or navigating the complexities of a specific genetic condition with PGT-M, these advancements open new doors to the possibilities of parenthood. 

The journey may be long or complex, but with the insights gained from genetic testing, it becomes a journey filled with hope, resilience, and the promise of a brighter tomorrow.